⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CNTX News
Context Therapeutics Inc. Common Stock
Context Therapeutics to Present at the Jefferies Global Healthcare Conference
globenewswire.com
CNTX
Form 8-K
sec.gov
CNTX
BCAB
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
globenewswire.com
CNTX
BCAB
Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
globenewswire.com
CNTX
Form 8-K
sec.gov
CNTX
Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary
businesswire.com
NEOG
CNTX
Form 8-K
sec.gov
CNTX
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
globenewswire.com
CNTX
Form 8-K
sec.gov
CNTX
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
globenewswire.com
CNTX